ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 189 filers reported holding ACORDA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,096,000 | -81.3% | 142,866 | -67.6% | 0.00% | -81.8% |
| Q1 2019 | $5,858,000 | +179.8% | 440,812 | +228.0% | 0.02% | +144.4% |
| Q4 2018 | $2,094,000 | +19.9% | 134,411 | +51.1% | 0.01% | +50.0% |
| Q3 2018 | $1,747,000 | +1027.1% | 88,929 | +1549.6% | 0.01% | +500.0% |
| Q2 2018 | $155,000 | – | 5,391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |